Bernhard Hellmich - Concepedia

Author

Bernhard Hellmich

Also Known As

Alberto Sinico, Renato, B HELLMICH, B Hellmich, B. HELLMICH, B. Hellmich, B. Hellmich, BERNHARD HELLMICH, Bernhard Hellmich, Gulen Hatemi, Hellmich B.

580

Publications

14.1K

Citations

H-Index

Concepts

All Affiliations

University of Lübeck University Hospital Schleswig-Holstein University of Tübingen HNO Bad Bramstedt Ruhr University Bochum

About

Bernhard Hellmich is an author at University of Lübeck specializing in medicine, immunology, and autoimmune disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	976
2	Health Sciences	1	1	40
3	Public Health	1	1	51
4	Social Sciences	1	1	15
5	Allergy	1	1	72

Bernhard Hellmich

Publications

10K

Citations

H-Index

Page 1

	Year	Citations
Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies Richard Watts, Suzanne Lane, Thomas Hanslik, Annals of the Rheumatic Diseases	2006	1.3K
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis Max Yates, Richard A. Watts, Ingeborg M. Bajema, Annals of the Rheumatic Diseases	2016	1.2K
2018 Update of the EULAR recommendations for the management of large vessel vasculitis Bernhard Hellmich, Ana Águeda, Sara Monti, Annals of the Rheumatic Diseases	2019	1.1K
EULAR recommendations for the management of primary small and medium vessel vasculitis Chetan Mukhtyar, Loı̈c Guillevin, María C. Cid, Annals of the Rheumatic Diseases	2008	984
EULAR recommendations for the management of large vessel vasculitis Chetan Mukhtyar, Loı̈c Guillevin, María C. Cid, Annals of the Rheumatic Diseases	2008	665
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Ivan Solovič, Martina Sester, Juan J. Gómez‐Reino, European Respiratory Journal Clinical ImmunologyImmunodeficienciesTuberculosis PreventionImmunologyImmune Regulation	2010	512
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial Marco Matucci‐Cerinic, D.E. Furst, Maureen D. Mayes, Annals of the Rheumatic Diseases	2010	489
Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease Cem Gabay, Bruno Fautrel, Jürgen Rech, Annals of the Rheumatic Diseases	2018	284
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients Frank Moosig, Jan Phillip Bremer, Bernhard Hellmich, Annals of the Rheumatic Diseases	2012	273
Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis Claudia Metzler, N. Miehle, Karin Manger, Lara D. Veeken	2007	220

Page 1